Best Income Companies To Watch For 2014

Alaska Air Group (NYSE: ALK  ) may be the best airline available to investors. It's been incredibly successful in its slow, steady expansion plan that not only increases routes but increases revenue per seat along the way. It's no secret either, as the stock has gone up north of 80% in the last 12 months. Yet, even with its tremendous run-up in stock price, the company still trades under 10 times forward earnings. Let's take a look at the first quarter and see if it's time to back up the truck for Alaska Air.

Earnings recap
The company is off to a great start in 2013, achieving profitability in the first quarter for the fourth time in a row, according to CEO Bradley Tilden. The first quarter is typically a difficult one for airlines, as there is typically a sharp drop-off from the fourth quarter's holiday travel season. This quarter was a record first quarter for the airline, hitting $44 million, or $0.62 per share, in net income. Last year, the company managed just $28 million, or $0.39 per share. The Street seemed to expect around $0.56 per share, kicking off a nice beat on the bottom line.

Top 5 Low Price Companies To Watch In Right Now: Unilife Corporation(UNIS)

Unilife Corporation, together with its subsidiaries, engages in the development and manufacture of advanced drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a prefilled syringe designed for safe, simple, and convenient use by either healthcare workers or patients who self-administer prescription medication; and Unitract 1mL Syringes that are primarily designed for the subcutaneous injection of drugs within healthcare facilities and by patients who self-administer prescription medication, such as insulin. Its pipeline products include Unifill Select syringes, which facilitate the use of injectable drugs and vaccines between 0.2 and 1.5mL in volume that are supplied in either a liquid stable form or lyophilized for reconstitution; Unifill EZMix for the unmet needs of pharmaceutical companies seeking a delivery system for the reconstitution and administration of lyophilized drugs and vaccines; Unifill Auto-Injectors for the a ccurate, intuitive, and convenient administration of injectable drugs by patients outside of healthcare facilities; and Auto-Infusors, a range of single-use and disposable subcutaneous infusion systems for the patient self-injection of drugs between 3mL and 10mL in volume; and a novel device for the administration of a drug to a target organ. Unilife?s target customers include pharmaceutical and biotechnology companies seeking to optimize drug lifecycles and generate differentiation for their brand in competitive therapeutic markets through the use of innovative devices that can improve patient care, protect healthcare workers, and prevent disease; and suppliers of medical equipment to healthcare facilities and distributors to patients who self-administer prescription medication. The company is headquartered in York, Pennsylvania.

Advisors' Opinion:

• [By Laura Brodbeck]

  Next week investors will be waiting for several key earnings reports includingSotheby�� (NYSE: BID), Unilife Corporation (NASDAQ: UNIS), DISH Network Corporation (NASDAQ: DISH), Macy�� Inc. (NYSE: M), Wal-Mart Stores, Inc. (NYSE: WMT)

• [By Paul Ausick]

  Stocks on the Move: Voxeljet AG (NYSE: VJET) is down 32.5% at $39.15 on both a momentum move and a scathing report from a short-seller. Unilife Corp. (NASDAQ: UNIS) is up 43.9% at $4.03 after signing a long-term contract for its syringes.

Best Income Companies To Watch For 2014: Rogue Resources Inc (RRS)

Rogue Resources Inc., formerly Rogue Iron Ore Corp., is an exploration-stage company. The Company is engaged in acquiring, exploring, and evaluating mineral properties located in Canada and the United States. The Company owns a 100% interest in Radio Hill Iron Ore property. The Radio Hill Iron Ore property consists of a 12,000 hectare land package located 85 kilometer southwest of Timmins, Ontario. Langmuir Property located seven kilometers by road from Liberty Mines Nickel mill, which has a capacity of 2000 tons/day. Langmuir Property is consists of 74 contiguous unpatented mining claims of 856 units (13,841 hectares). The Langmuir Property includes over 30 kilometer of terrain consists of ultramafic and mafic flows and sills for hosting nickel, copper and platinum group mineralization (PGM). As of April 1, 2012, the Company completed 31 drill holes at Radio Hill for a total of 7,828 meters. In March 2013, it completed the spin off its Rapier Gold Inc unit. Advisors' Opinion:

• [By Jonathan Morgan]

  Randgold Resources Ltd. (RRS), a gold miner in Africa, declined 5.6 percent to 4,428 pence. Fresnillo Plc, the world�� biggest primary silver producer, sank 11 percent to 924.5 pence after cutting its interim dividend by 68 percent from a year earlier because of a slump in precious-metal prices.

• [By Alexis Xydias]

  Randgold Resources Ltd. (RRS) led commodity producers higher amid signs of growing demand from the world�� second-biggest economy. BHP Billiton Ltd. (BHP) and Rio Tinto Group, the world�� largest mining companies, rallied more than 3 percent. Standard Life Plc (SL/) declined 3.3 percent as analysts raised concern about the insurer�� earnings.

• [By Namitha Jagadeesh]

  Randgold Resources Ltd. (RRS) slid 1.4 percent after second-quarter profit slumped 61 percent. BHP Billiton Ltd. (BHP) and Rio Tinto Group contributed the most to a decline by U.K. commodity producers. Old Mutual Plc (OML) advanced 2.9 percent after Africa�� biggest insurer said profit rose 14 percent in the first half.

Best Income Companies To Watch For 2014: Actavis Inc (ACT)

Actavis, Inc., formerly Watson Pharmaceuticals, Inc., incorporated on February 1, 1985, is a integrated global specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand, biosimilar and over-the-counter (OTC) pharmaceutical products. The Company also develops and out-licenses generic pharmaceutical products primarily in Europe through its Medis third-party business. The Company operates in three segments: Actavis Pharma, Actavis Specialty Brands and Anda Distribution. On January 23, 2013, the Company completed the acquisition of Uteron Pharma SA. On October 29, 2012, the Company sold its Rugby OTC pharmaceutical products and trademarks to The Harvard Drug Group, L.L.C. On January 24, 2012, the Company completed the acquisition of Ascent Pharmahealth Ltd.

Actavis Pharma Segment

Actavis Pharma Segment is engaged in the development, manufacturing and sale of generic, branded generic and OTC pharmaceutical products. The Company�� portfolio of generic products includes products it has developed internally and products licensed from and distributed for third parties. The Company sells its generic prescription products primarily under the Watson Laboratories, Watson Pharma and Actavis Pharma labels, and its over-the-counter generic products under private label.

Actavis Specialty Brands Segment

The Company markets a number of branded products to physicians, hospitals, and other markets that it serves. The Company classifies these trademarked products as its brand pharmaceutical products. In April 2012, it launched Gelnique 3% (oxybutynin), a clear, odorless topical gel. Gelnique 3% was obtained through an exclusive licensing agreement with Antares. The Company�� promoted products are Rapaflo, Gelnique, Trelstar, Androderm, Generess Fe and Crinone. The Company�� Actavis Specialty Brands segment also receives other revenues consisting of co-promotion revenue and royaltie! s.

Anda Distribution Segment

The Company Anda Distribution business primarily distributes generic and selected brand pharmaceutical products, vaccines, injectables and over-the-counter medicines to independent pharmacies, alternate care providers (hospitals, nursing homes and mail order pharmacies), pharmacy chains and physicians��offices. In addition, it sells to members of buying groups, which are independent pharmacies that join together to enhance their buying power. As of December 31, 2012, the Company distributes products from its facilities in Weston, Florida, Groveport, Ohio, and Olive Branch, Mississippi, as well as a small volume of product from Puerto Rico.

The Company competes with Teva Pharmaceutical Industries, Ltd., Mylan Inc., Sandoz, Inc, McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc.,

Advisors' Opinion:

• [By Louis Navellier]

  We still have a few weeks until Actavis Plc (ACT) reports Q4 earnings, but already ACT shares are rising on strong preannouncement news. What’s up with the generics giant? Is it time to buy? Find out now.

• [By Holly LaFon]

  The Fund's average overweight position (20% versus 13%) and holdings in the Health Care sector (up 8% compared to up 6% for the S&P 500 sector) contributed to results. Forest Laboratories (FRX) (up 54%) agreed to be acquired by Actavis PLC (ACT). Merck (up 14%) also performed well.

• [By Chris Mydlo]

  Now that the second quarter portfolios have been filed with the SEC, I used the GuruFocus S&P 500 Grid to get a look at what the hedge fund gurus have been buying. I prefer to use ��et buys��over ��uys��because it also factors in what the hedge fund gurus have been selling. When using the S&P 500 Grid, I adjusted the settings to only include the hedge fund gurus and examined the results for both S&P 500 and non-S&P 500 companies. The top results were MasterCard (MA), eBay (EBAY), Occidental Petroleum (OXY), Ally Financial (ALLY), Actavis (ACT), and Allergan (AGN).

• [By Rich Smith]

  On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX  ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT  ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.

Best Income Companies To Watch For 2014: Rentech Inc (RTK)

Rentech, Inc. (Rentech), incorporated in 1981, is a provider of clean energy solutions. The Company owns and operates a nitrogen fertilizer plant in East Dubuque, Illinois, that manufactures and sells natural gas-based nitrogen fertilizer products within the corn-belt region in the United States. It is developing energy projects to produce certified synthetic fuels and electric power from carbon-containing materials, such as biomass, waste and fossil resources. Its technologies can produce synthesis gas (syngas) from biomass and waste materials, and convert syngas from its own or other gasification technologies into complex hydrocarbons (the Rentech Process) that are then upgraded into fuels using refining technology that it licenses. In addition to developing projects using these technologies, it is pursuing the licensing of its technologies to developers of projects that are expected to produce fuels and/or power. In May 2011, it acquired majority interest in ClearFuels Technology Inc. In May 2013, Rentech Inc acquired the entire share capital of Fulghum Fibres Inc. In August 2013, Rentech Inc announced that a subsidiary of the Company closed the sale of approximately 450 acres in Natchez, Mississippi to Adams County, Mississippi.

The Rentech Process is a technology based on Fischer-Tropsch (FT) chemistry, which converts syngas that can be produced from a range of biomass, waste and fossil resources into hydrocarbons. These hydrocarbons can be processed and upgraded into synthetic fuels, such as military and commercial jet fuels and low sulfur diesel fuel, as well as waxes and chemicals. Unlike some other alternative transportation fuels, such as ethanol, fuels produced from the Rentech Process can be transported and used in existing infrastructure, including pipelines and engines without blending restrictions. Its technology portfolio also includes the Rentech-SilvaGas biomass gasification technology (the Rentech-SilvaGas Technology), which enables it to offer integrated technologies t! hat can convert biomass and wastes to syngas and into clean fuels and electric power.

The Rentech Process can produce synthetic diesel fuels (RenDiesel1 fuels), which are clean burning having lower emissions of regulated pollutants, such as nitrogen oxides, sulfur oxides and particulate matter, than traditional petroleum-based diesel fuels. The Rentech Process also can produce synthetic jet fuel (RenJet fuel), which when blended with conventional jet fuel meet jet fuel specifications for military jet fuel and commercial Jet A and Jet A-1 fuels. It is developing a proposed project near Natchez, Mississippi (the Natchez Project) designed to produce approximately 30,000 barrels per day of synthetic fuels and chemicals and approximately 120 megawatts of power. It is evaluating alternative configurations for the Natchez site, which would initially be smaller in scale. The alternate configurations may use various feed-stocks alone or in various combinations, and include proportions of waxes and chemicals as products.

The Company owns, through its wholly owned subsidiary, Rentech Energy Midwest Corporation (REMC), a nitrogen fertilizer manufacturing plant that uses natural gas as its feedstock to produce syngas and then nitrogen fertilizer products. The products, the Company can produce include renewable synthetic diesel and jet fuels, naphtha and power from biomass resources; synthetic diesel and jet fuels, naphtha and power from fossil or fossil and biomass resources, and paraffinic waxes, solvents and specialty chemicals.

The Company competes with ExxonMobil, the Royal Dutch/Shell group, Statoil, BP and Sasol.

Advisors' Opinion:

• [By Robert Rapier] While the MLP space is dominated by the oil and gas sector, in last week’s article we began to explore some of the more exotic master limited partnership offerings. This week we continue our exploration of nontraditional MLPs by looking at the partnerships supplying fertilizer.
  
  Rentech (Nasdaq: RTK) has been around for more than a decade, and it has shifted strategies several times. Full disclosure: Rentech’s Chief Technology Officer Harold Wright is a former manager of mine when we were both at ConocoPhillips, and I have visited Rentech’s facility in Commerce City, Colorado.
  
  For most of Rentech’s existence, the company has sought to commercialize alternative fuels. At one time it had ambitions to build a large coal-to-liquids (CTL) plant, but federal legislation ultimately nudged it instead into the biomass-to-liquids (BTL) space. The company did build a BTL demonstration plant, but ultimately shut it down and has now refocused its efforts on becoming “one of the largest wood processing companies in the world.”
  
  During its interesting journey as a company, Rentech acquired two ammonia nitrogen fertilizer facilities, which turned out to be a profit center that funded the alternative energy research. In November 2011, Rentech spun off this fertilizer business into an MLP called Rentech Nitrogen Partners LP (NYSE: RNF).
  
  In the months leading to the spin-off, RTK’s market capitalization was about $200 million. Rentech maintained 60 percent ownership of RNF, and three months after the spin-off RTK’s market cap had risen to $400 million, while investors had bid RNF up to $1 billion. Interestingly, RTK’s share of RNF was worth more than RTK’s entire market cap, a situation that persists. The market currently values Rentech at $482 million, while the valuation of Rentech Nitrogen Partners makes RTK’s 60 percent stake in RNF worth slightly more than $600 million — another illu
• [By Travis Hoium]

  What: Shares of fertilizer and renewable energy company Rentech (NASDAQ: RTK  ) jumped 17% today after the company announced an acquisition.